Print Page   |   Contact Us   |   Report Abuse   |   Sign In   |   Register
Pharmaceutical Trials
Blog Home All Blogs
Search all posts for:   

 

View all (108) posts »
 

Outstanding pharma: Nov. 13-20

Posted By David L. Evans, Thursday, November 13, 2014
Updated: Wednesday, November 19, 2014

Outstanding pharma: Nov. 13-20

Great news

Controversial drug lowers cholesterol

http://www.scientificamerican.com/article/controversial-cholesterol-drug-reduces-risk-of-heart-disease/?WT.mc_id=SA_DD_20141118

Complete, free report from Sci. Am.

Statins reverse one learning disability

http://www.dddmag.com/news/2014/11/statins-reverse-learning-disabilities-caused-genetic-disorder?et_cid=4269654&et_rid=54713780&location=top

Full, free item from Drug discov. & develop.

Delivering anti-HIV drug through milk

http://www.biosciencetechnology.com/news/2014/11/altered-milk-protein-can-deliver-aids-drug-infants?et_cid=4259358&et_rid=54713780&location=top

Complete, free report from Biosci. Tech.

Antidote for carbon monoxide is injectable

http://www.dddmag.com/news/2014/11/injectable-antidote-carbon-monoxide-poisoning?et_cid=4263682&et_rid=54713780&location=top

Full, free essay from Drug discov. & develop.

Not-so-great news

How much to bring a drug to market: $2.6 billion

http://www.genengnews.com/gen-news-highlights/tufts-study-pegs-drug-development-approval-cost-at-2-6b/81250610/

Complete, free report from GEN

Why microbicides don't work against HIV currently

http://www.scientificamerican.com/podcast/episode/semen-protects-hiv-from-microbicide-attack/?WT.mc_id=SA_DD_20141117

Short, free audio file from Sci. Am.

B-vitamins v cognitive decline in elders? Nope.

http://www.neurology.org/content/early/2014/11/12/WNL.0000000000001050

Free abstract from Neurology

Ethical questions in Ebola drug testing

http://www.dddmag.com/news/2014/11/ebola-drug-testing-sparks-ethics-debate?et_cid=4263006&et_rid=54713780&location=top

Full, free essay from Drug discov. & develop.


 

This post has not been tagged.

Permalink | Comments (0)